NRX Pharmaceuticals
NRXP
NRXP
34 hedge funds and large institutions have $965K invested in NRX Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
80% less capital invested
Capital invested by funds: $4.78M → $965K (-$3.82M)
Holders
34
Holding in Top 10
–
Calls
$42K
Puts
$1K
Top Buyers
| 1 | +$40.9K | |
| 2 | +$34.2K | |
| 3 | +$13.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.65K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.67K |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$234K | |
| 3 | -$97.4K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.5K |
| 5 |
Jane Street
New York
|
-$7.28K |